{"podcast":{"title":"The AI in Business Podcast","slug":"the-ai-in-business-podcast-168928","podcast_index_feed_id":168928,"rss_url":"https://techemergence.libsyn.com/rss","website_url":"http://emerj.com","image_url":"https://static.libsyn.com/p/assets/9/c/2/2/9c226d0d338dd5bed959afa2a1bf1c87/1.png","author":"Daniel Faggella","episode_count":1163,"summary":"The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI. Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption. Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise","last_synced_at":"2026-07-04T00:20:08.438260+00:00","page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928"},"episode":{"title":"Breaking Bottlenecks in Life Sciences R&D with AI Innovation - with Aziz Nazha of Incyte Pharmaceuticals","slug":"breaking-bottlenecks-in-life-sciences-r-d-with-ai-innovation-with-aziz-nazha-of-incyte-pharmaceuticals","published_at":"2026-04-16T15:00:00+00:00","page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928/breaking-bottlenecks-in-life-sciences-r-d-with-ai-innovation-with-aziz-nazha-of-incyte-pharmaceuticals","show_page_url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928","url":"https://podcast.emerj.com/breaking-bottlenecks-in-life-sciences-rd-with-ai-innovation-with-aziz-nazha-of-incyte-pharmaceuticals","audio_url":"https://traffic.libsyn.com/secure/techemergence/Business_-_4.16.26_-_Aziz_Nazha.mp3?dest-id=151434","summary":"R&D teams are starting to advance AI capabilities faster than they can translate them into measurable business value, creating mounting friction between scientific progress and operational reality. In this episode, Aziz Nazha, Global Head of AI Innovations Institute at Incyte Pharmaceuticals, examines how culture, talent, infrastructure, and expectation‑setting determine whether AI meaningfully improves drug discovery and development. He highlights the practical shifts required — from redesigning workflows to disciplined upskilling and targeted validation cycles — to ensure AI adoption accelerates cycle times rather than getting stalled by organizational bottlenecks. This episode is sponsored by Deloitte. Learn how brands like Deloitte work with Emerj and other Emerj Media options at go.emerj.com/partner","meta_description":"R&D teams are starting to advance AI capabilities faster than they can translate them into measurable business value, creating mounting friction betwe…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1857,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-ai-in-business-podcast-168928/episodes/breaking-bottlenecks-in-life-sciences-r-d-with-ai-innovation-with-aziz-nazha-of-incyte-pharmaceuticals/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-ai-in-business-podcast-168928/breaking-bottlenecks-in-life-sciences-r-d-with-ai-innovation-with-aziz-nazha-of-incyte-pharmaceuticals.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}